Meditation-Related Adverse Effects Scale- Mindfulness Based Program Version (MRAES- MBP)
The Meditation-Related Adverse Effects Scale, Mindfulness-Based Program version (MRAES-MBP) was derived from more than 150 qualitative-interviews with Buddhist meditators, meditation teachers and Mindfulness-based program participants about distressing and/or impairing meditation-related experiences (Britton et al., 2021; Lindahl, Fisher, Cooper, Rosen, & Britton, 2017). For the MBP version of the MRAE (MRAES-MBP), categories of meditation-related experiences that were most common and/or most highly associated with negatively impact in functioning in the context of a mindfulness based-program were prioritized and less common and/or more serious meditation-related experiences (involuntary movements, psychosis, mania) were not included. The final 10 items were selected by three content experts through a modified Delphi method. The Meditation-Related Adverse Effects Scale, Mindfulness-Based Program version (MRAES-MBP) scale represents the 10 common and/or most highly associated with negatively impact in functioning in the context of a mindfulness based-program, specifically signs of hyper arousal: (anxiety, perceptual hypersensitivity, traumatic re-experiencing, emotional lability, insomnia) hypo-arousal/blunting (anhedonia, depersonalization) executive dysfunction and social disengagement. Items were derived from were derived from the NIH toolbox Patient-Reported Outcomes Management Information System (PROMIS) (Cella et al., 2007) and/or Neuro-QOL (Cella et al., 2012) anxiety, depression, Emotional and Behavioral Dyscontrol, and cognitive function item bank and other validated measures of clinically-relevant symptoms (Dell, 2006; Lang & Stein, 2005; Mason et al., 2008; Schat et al., 2005). An 11th item uses an optional free text format to inquire about other meditation related experiences that were not queried.
REFERENCES:
Britton, W. B., Lindahl, J. R., Cooper, D. J., Canby, N. K., & Palitsky, R. (2021). Defining and measuring meditation-related adverse effects in mindfulness-based interventions. Clinical Psychological Science. doi:doi.org/10.1177/2167702621996340
Cella, D., Lai, J. S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., . . . Moy, C. (2012). Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology, 78(23), 1860-1867. doi:10.1212/WNL.0b013e318258f744
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., . . . Group, P. C. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care, 45(5 Suppl 1), S3-S11. doi:10.1097/01.mlr.0000258615.42478.55
Dell, P. F. (2006). The multidimensional inventory of dissociation (MID): A comprehensive measure of pathological dissociation. J Trauma Dissociation, 7(2), 77-106. doi:10.1300/J229v07n02_06
Goldberg, S. B., Lam, S. U., Britton, W. B., & Davidson, R. J. (2021). Prevalence of meditation-related adverse effects in a population-based sample in the United States. Psychother Res, 1-15. doi:10.1080/10503307.2021.1933646
Lang, A. J., & Stein, M. B. (2005). An abbreviated PTSD checklist for use as a screening instrument in primary care. Behav Res Ther, 43(5), 585-594. doi:10.1016/j.brat.2004.04.005
Lindahl, J. R., Fisher, N. E., Cooper, D. J., Rosen, R. K., & Britton, W. B. (2017). The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists. PLoS One, 12(5), e0176239. doi:10.1371/journal.pone.0176239
Mason, O. J., Morgan, C. J., Stefanovic, A., & Curran, H. V. (2008). The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophr Res, 103(1-3), 138-142. doi:10.1016/j.schres.2008.02.020
Schat, A. C. H., Kelloway, E. K., & Desmarais, S. (2005). The Physical Health Questionnaire (PHQ): construct validation of a self-report scale of somatic symptoms. J Occup Health Psychol, 10(4), 363-381. doi:10.1037/1076-8998.10.4.363
The MRAES-MBP scale is available for research purposes. Click the button on the left to fill out a form and download the scale and manual